189 research outputs found
HYDROLOGIC EFFECTS OF CLIMATE AND LAND USE CHANGE IN SMALL MARYLAND WATERSHEDS
The impact of a changing climate combined with a more urbanized world signals a change in watershed behavior. This work aims to quantify the change in watershed runoff due to both climate change and land use shifts by modeling changes in peak flow rates, duration of storm runoff, and the time to peak flow in response to storms of differing frequencies. GISHydro and WinTR-20 were used in tandem to model the effects of urbanization and increased rainfall predicted at mid-21st century on six small watersheds in two geographic regions of Maryland. Results indicate that climate change is the more influential factor in altering runoff for events from 50% to 1% annual exceedance probability; however, land use change is most prominently felt during the more common storms. Furthermore, a non-linear relationship is observed between the effects of impervious surface and rainfall on the runoff potential of the watersheds
Recommended from our members
Risks, successes, and failures in United States nuclear weapon policy
This thesis evaluates the successes and failures from past United States nuclear weapon policy and discusses the modern-day risks that resulted from either past policy developments or changes in the modern nuclear environment. In 1945, the United States solely possessed nuclear weapons following the Manhattan Project, and promptly decided to use them to force Japan to surrender from World War II. Despite the United Statesâ best efforts to keep the technology secret, nuclear technology proliferated quickly to the Soviet Union, followed by several other countries. The United States and Soviet Union navigated an exceptional arms race throughout the Cold War, conducting thousands of nuclear tests to advance nuclear technology, some of which resulted in harm to the public and the environment. Cognizant of the implications of their growing nuclear stockpiles, the United States and Soviet Union reached several agreements restricting nuclear weapons. These agreements have faltered in recent years, and there are several other developments that contribute risk to the global nuclear environment, including Chinaâs rapid nuclear development, the deterioration of the aging United States stockpile, and inconsistencies in relations with Iran, India, Pakistan, North Korea, Taiwan, and Israel. The United States is entering a new, multifaceted nuclear environment with several new nuclear actors that were not prevalent during the Cold War. The United States must address these new intricacies without turning a blind eye to the developing relationship between China and Russia.Mechanical Engineerin
Human Health
Peer-Reviewed Paper.
DOI: https://doi.org/10.14465/2017.arc10.008-huhâą Toxin producing phytoplankton, pathogenic vibrios (bacteria commonly found in low salinity water) and noroviruses all
have the potential to impact human health.
âą The relationship between climate change and toxin producing phytoplankton is complex. Considerable unknowns remain
about how climate change will impact this part of the plankton community and confidence in predicting these impacts in
UK waters remains low.
âą A recent study in Scotland has shown short term weather events as well as wind mediated transport of offshore phytoplankton
populations can influence the toxicity of coastal shellfish. This highlights the requirement for long term data sets to identify
the impacts of climate change from shorter term seasonal and interannual variability.
âą Emerging evidence from peer-reviewed scientific studies has suggested that increasing seawater temperatures and extreme
weather events such as heatwaves and extreme precipitation, drive the abundance of pathogenic vibrios in the environment.
A recent spate of reported infections in Northern Europe underlines these observations. Climate warming in the region may
therefore increase human infections
TLR 2 and 4 responsiveness from isolated peripheral blood mononuclear cells from rats and humans as potential chronic pain biomarkers
Background: Chronic pain patients have increased peripheral blood mononuclear cell Interkeukin-1ÎČ production following TLR2 and TLR4 simulation. Here we have used a human-to-rat and rat-to-human approach to further investigate whether peripheral blood immune responses to TLR agonists might be suitable for development as possible systems biomarkers of chronic pain in humans. Methods and Results: Study 1: using a graded model of chronic constriction injury in rats, behavioral allodynia was assessed followed by in vitro quantification of TLR2 and TLR4 agonist-induced stimulation of IL-1ÎČ release by PBMCs and spinal cord tissues (n = 42; 6 rats per group). Statistical models were subsequently developed using the IL-1ÎČ responses, which distinguished the pain/no pain states and predicted the degree of allodynia. Study 2: the rat-derived statistical models were tested to assess their predictive utility in determining the pain status of a published human cohort that consists of a heterogeneous clinical pain population (n = 19) and a pain-free population (n = 11). The predictive ability of one of the rat models was able to distinguish pain patients from controls with a ROC AUC of 0.94. The rat model was used to predict the presence of pain in a new chronic pain cohort and was able to accurately predict the presence of pain in 28 out of the 34 chronic pain participants. Conclusions: These clinical findings confirm our previous discoveries of the involvement of the peripheral immune system in chronic pain. Given that these findings are reflected in the prospective graded rat data, it suggests that the TLR response from peripheral blood and spinal cord were related to pain and these clinical findings do indeed act as system biomarkers for the chronic pain state. Hence, they provide additional impetus to the neuroimmune interaction to be a drug target for chronic pain.Yuen H. Kwok, Jonathan Tuke, Lauren L. Nicotra, Peter M. Grace, Paul E. Rolan, Mark R. Hutchinso
Detection of Tetrodotoxin Shellfish Poisoning (TSP) Toxins and Causative Factors in Bivalve Molluscs from the UK
Publication history: Accepted - 28 August 2017; Published online - 30 August 2017.Tetrodotoxins (TTXs) are traditionally associated with the occurrence of tropical Pufferfish Poisoning. In recent years, however, TTXs have been identified in European bivalve mollusc shellfish, resulting in the need to assess prevalence and risk to shellfish consumers. Following the previous identification of TTXs in shellfish from southern England, this study was designed to assess the wider prevalence of TTXs in shellfish from around the coast of the UK. Samples were collected between 2014 and 2016 and subjected to analysis using HILIC-MS/MS. Results showed the continued presence of toxins in shellfish harvested along the coast of southern England, with the maximum concentration of total TTXs reaching 253 ”g/kg. TTX accumulation was detected in Pacific oysters (Crassostrea gigas), native oysters (Ostrea edulis) common mussels (Mytilus edulis) and hard clams (Mercenaria mercenaria), but not found in cockles (Cerastoderma edule), razors (Ensis species) or scallops (Pecten maximus). Whilst the highest concentrations were quantified in samples harvested during the warmer summer months, TTXs were still evident during the winter. An assessment of the potential causative factors did not reveal any links with the phytoplankton species Prorocentrum cordatum, instead highlighting a greater level of risk in areas of shallow, estuarine waters with temperatures above 15 °CFunding from Cefas internal funding sources (Seedcorn, DP345B and DP402); and FS
Diet in the driving seat: natural diet-immunity-microbiome interactions in wild fish
Natural interactions between the diet, microbiome and immunity are largely unstudied. Here we employ wild three-spined
sticklebacks as a model, combining field observations with complementary experimental manipulations of diet designed to mimic
seasonal variation in the wild. We clearly demonstrate that season-specific diets are a powerful causal driver of major systemic
immunophenotypic variation. This effect occurred largely independently of the bulk composition of the bacterial microbiome (which
was also driven by season and diet) and of host condition, demonstrating neither of these, per se, constrain immune allocation in
healthy individuals. Nonetheless, through observations in multiple anatomical compartments, differentially exposed to the direct
effects of food and immunity, we found evidence of immune-driven control of bacterial community composition in mucus layers.
This points to the interactive nature of the host-microbiome relationship, and is the first time, to our knowledge, that this causal
chain (diet â immunity â microbiome) has been demonstrated in wild vertebrates. Microbiome effects on immunity were not
excluded and, importantly, we identified outgrowth of potentially pathogenic bacteria (especially mycolic-acid producing
corynebacteria) as a consequence of the more animal-protein-rich summertime diet. This may provide part of the ultimate
explanation (and possibly a proximal cue) for the dramatic immune re-adjustments that we saw in response to diet change
Trace amine-associated receptor 1 (TAAR1) agonism for psychosis:a living systematic review and meta-analysis of human and non-human data
BACKGROUND: Trace amine-associated receptor 1 (TAAR1) agonism shows promise for treating psychosis, prompting us to synthesise data from human and non-human studies.METHODS: We co-produced a living systematic review of controlled studies examining TAAR1 agonists in individuals (with or without psychosis/schizophrenia) and relevant animal models. Two independent reviewers identified studies in multiple electronic databases (until 17.11.2023), extracted data, and assessed risk of bias. Primary outcomes were standardised mean differences (SMD) for overall symptoms in human studies and hyperlocomotion in animal models. We also examined adverse events and neurotransmitter signalling. We synthesised data with random-effects meta-analyses.RESULTS: Nine randomised trials provided data for two TAAR1 agonists (ulotaront and ralmitaront), and 15 animal studies for 10 TAAR1 agonists. Ulotaront and ralmitaront demonstrated few differences compared to placebo in improving overall symptoms in adults with acute schizophrenia (N=4 studies, n=1291 participants; SMD=0.15, 95%CI: -0.05, 0.34), and ralmitaront was less efficacious than risperidone (N=1, n=156, SMD=-0.53, 95%CI: -0.86, -0.20). Large placebo response was observed in ulotaront phase-III trials. Limited evidence suggested a relatively benign side-effect profile for TAAR1 agonists, although nausea and sedation were common after a single dose of ulotaront. In animal studies, TAAR1 agonists improved hyperlocomotion compared to control (N=13 studies, k=41 experiments, SMD=1.01, 95%CI: 0.74, 1.27), but seemed less efficacious compared to dopamine D 2 receptor antagonists (N=4, k=7, SMD=-0.62, 95%CI: -1.32, 0.08). Limited human and animal data indicated that TAAR1 agonists may regulate presynaptic dopaminergic signalling. CONCLUSIONS: TAAR1 agonists may be less efficacious than dopamine D 2 receptor antagonists already licensed for schizophrenia. The results are preliminary due to the limited number of drugs examined, lack of longer-term data, publication bias, and assay sensitivity concerns in trials associated with large placebo response. Considering their unique mechanism of action, relatively benign side-effect profile and ongoing drug development, further research is warranted. REGISTRATION: PROSPERO-ID: CRD42023451628.</p
IL-4 Deficiency Is Associated with Mechanical Hypersensitivity in Mice
Interleukin-4 (IL-4) is an anti-inflammatory and analgesic cytokine that induces opioid receptor transcription. We investigated IL-4 knockout (ko) mice to characterize their pain behavior before and after chronic constriction injury (CCI) of the sciatic nerve as a model for neuropathic pain. We investigated opioid responsivity and measured cytokine and opioid receptor gene expression in the peripheral and central nervous system (PNS, CNS) of IL-4 ko mice in comparison with wildtype (wt) mice. NaĂŻve IL-4 ko mice displayed tactile allodynia (wt: 0.45 g; ko: 0.18 g; p<0.001), while responses to heat and cold stimuli and to muscle pressure were not different. No compensatory changes in the gene expression of tumor necrosis factor-alpha (TNF), IL-1ÎČ, IL-10, and IL-13 were found in the PNS and CNS of naĂŻve IL-4 ko mice. However, IL-1ÎČ gene expression was stronger in the sciatic nerve of IL-4 ko mice (p<0.001) 28 days after CCI and only IL-4 ko mice had elevated IL-10 gene expression (pâ=â0.014). Remarkably, CCI induced TNF (p<0.01), IL-1ÎČ (p<0.05), IL-10 (p<0.05), and IL-13 (p<0.001) gene expression exclusively in the ipsilateral spinal cord of IL-4 ko mice. The compensatory overexpression of the anti-inflammatory and analgesic cytokines IL-10 and IL-13 in the spinal cord of IL-4 ko mice may explain the lack of genotype differences for pain behavior after CCI. Additionally, CCI induced gene expression of ÎŒ, Îș, and ÎŽ opioid receptors in the contralateral cortex and thalamus of IL-4 ko mice, paralleled by fast onset of morphine analgesia, but not in wt mice. We conclude that a lack of IL-4 leads to mechanical sensitivity; the compensatory hyperexpression of analgesic cytokines and opioid receptors after CCI, in turn, protects IL-4 ko mice from enhanced pain behavior after nerve lesion
Is biotechnology (more) acceptable when it enables a reduction in phytosanitary treatments? A European comparison of the acceptability of transgenesis and cisgenesis
Reduced pesticide use is one of the reasons given by Europeans for accepting new genetic engineering techniques. According to the advocates of these techniques, consumers are likely to embrace the application of cisgenesis to apple trees. In order to verify the acceptability of these techniques, we estimate a Bayesian multilevel structural equation model, which takes into account the multidimensional nature of acceptability and individual, national, and European effects, using data from the Eurobarometer 2010 73.1 on science. The results underline the persistence of clear differences between European countries and whilst showing considerable defiance, a relatively wider acceptability of vertical gene transfer as a means of reducing phytosanitary treatments, compared to horizontal transfer
Inducible nitric oxide synthase inhibition by 1400W limits pain hypersensitivity in a neuropathic pain rat model
Peripheral neuropathic pain (PNP), resulting from injury to or dysfunction of a peripheral nerve, is a major health problem that affects 7â8% of the population. It is inadequately controlled by current drugs and is characterized by pain hypersensitivity, which is believed to be attributable to sensitization of peripheral and CNS neurons by various inflammatory mediators. Here we examined, in a rat model of PNP: (i) whether reducing levels of nitric oxide (NO) with 1400W, a highly selective inhibitor of inducible NO synthase (iNOS), would prevent or attenuate pain hypersensitivity; and (ii) the effects of 1400W on plasma concentrations of several cytokines that are secreted after iNOS upregulation during chronic pain states. The L5 spinal nerve axotomy (SNA) model of PNP was used, and 1400W (20 mg kgâ1) was administered i.p . at 8 h intervals for 3 days starting at 18 h postâSNA. Changes in plasma concentrations of 12 cytokines in SNA rats treated with 1400W were examined using multiplex enzymeâlinked immunosorbent assay. The SNA rats developed behavioural signs of mechanical and heat hypersensitivity. Compared with the vehicle/control, 1400W significantly: (i) limited development of mechanical hypersensitivity at 66 h postâSNA and of heat hypersensitivity at 42 h and at several time points tested thereafter; and (ii) increased the plasma concentrations of interleukin (IL)â1α, ILâ1ÎČ and ILâ10 in the SNA rats. The findings suggest that 1400W might exert its analgesic effects by reducing iNOS and altering the balance between the proâinflammatory (ILâ1ÎČ and ILâ1α) and antiâinflammatory (ILâ10) cytokines and that therapies targeting NO or its enzymes might be effective for the treatment of PNP
- âŠ